nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of continuous enzyme kinetic data using ICEKAT
|
Bursch, Karina L. |
|
|
690 |
C |
p. 109-129 |
artikel |
2 |
Analysis of enzyme reactions using NMR techniques: A case study with α-methylacyl-CoA racemase (AMACR)
|
Woodman, Timothy J. |
|
|
690 |
C |
p. 159-209 |
artikel |
3 |
Contributors
|
|
|
|
690 |
C |
p. xvii-xx |
artikel |
4 |
Copyright
|
|
|
|
690 |
C |
p. iv |
artikel |
5 |
Crystallographic fragment screening in academic cancer drug discovery
|
Martin, Mathew P. |
|
|
690 |
C |
p. 211-234 |
artikel |
6 |
Design and evaluation of substrate–product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism
|
Bearne, Stephen L. |
|
|
690 |
C |
p. 397-444 |
artikel |
7 |
Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis
|
Pang, Allan H. |
|
|
690 |
C |
p. 369-396 |
artikel |
8 |
Fast fragment and compound screening pipeline at the Swiss Light Source
|
Stegmann, Dennis Peter |
|
|
690 |
C |
p. 235-284 |
artikel |
9 |
Fragment-based screening by protein-detected NMR spectroscopy
|
Kerber, Paul J. |
|
|
690 |
C |
p. 285-310 |
artikel |
10 |
Half Title Page
|
|
|
|
690 |
C |
p. i |
artikel |
11 |
High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation
|
Russell, Drake A. |
|
|
690 |
C |
p. 341-368 |
artikel |
12 |
Identification and biochemical characterization of small molecule inhibitors of ERK2 that target the D-recruitment site
|
Sammons, R.M. |
|
|
690 |
C |
p. 445-499 |
artikel |
13 |
Mass cytometry as a tool in target validation and drug discovery
|
Watson, Edmund C.R. |
|
|
690 |
C |
p. 541-574 |
artikel |
14 |
Methods for computer-assisted PROTAC design
|
Rovers, Evianne |
|
|
690 |
C |
p. 311-340 |
artikel |
15 |
Non-equilibrium modalities of inhibition: Characterizing irreversible inhibition for the ErbB receptor family members
|
Srinivasan, Bharath |
|
|
690 |
C |
p. 85-108 |
artikel |
16 |
Preface
|
|
|
|
690 |
C |
p. xxi-xxiv |
artikel |
17 |
Preparing recombinant “Split AEP” for protein labeling
|
Ma, Muge |
|
|
690 |
C |
p. 501-540 |
artikel |
18 |
Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR)
|
Mojanaga, Otsile O. |
|
|
690 |
C |
p. 1-37 |
artikel |
19 |
Series Page
|
|
|
|
690 |
C |
p. ii |
artikel |
20 |
Steady-state kinetic analysis of reversible enzyme inhibitors: A case study on calf intestine alkaline phosphatase
|
Brooke, Henry |
|
|
690 |
C |
p. 39-84 |
artikel |
21 |
Title Page
|
|
|
|
690 |
C |
p. iii |
artikel |
22 |
You get what you screen for: Standards for experimental design and data fitting in drug discovery
|
Johnson, Kenneth A. |
|
|
690 |
C |
p. 131-157 |
artikel |